Related Experiment Video
Updated: May 12, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
Aspergillus fumigatus during stable state and exacerbations of COPD
Mona Bafadhel1, Susan McKenna, Joshua Agbetile
1Nuffield Department of Medicine, University of Oxford, Oxford.
Abstract:
Bacteria are often isolated in stable chronic obstructive pulmonary disease (COPD). Whether fungi are also commonly present and associated with clinical and pathological features of disease is uncertain. We investigated the frequency of filamentous fungal culture and IgE sensitisation to Aspergillus fumigatus and the relationship to clinical outcomes in COPD subjects. COPD subjects were recruited to enter a 1-year observational study. Assessments of lung function, allergen testing and sputum analysis for inflammation, bacteria and fungus were undertaken in COPD subjects and healthy smoking and nonsmoking controls. Filamentous fungi were cultured at baseline in 49% (63 out of 128) of COPD subjects, of which 75% (47 out of 63) were A. fumigatus. Fungus was cultured in three out of 22 controls (two were A. fumigatus). The total sputum cell count and inhaled corticosteroid dosage were significantly increased in COPD patients with a positive filamentous fungal culture at baseline (p<0.05). Sensitisation to A. fumigatus was present in 13% of COPD subjects and was associated with worse lung function (forced expiratory volume in 1 s 39% predicted versus 51% predicted; p=0.01), but not related to filamentous fungal culture. A. fumigatus sensitisation is related to poor lung function. Positive filamentous fungal culture is a common feature of COPD. The clinical significance of this remains uncertain.
Insights
Filamentous fungi, including Aspergillus fumigatus, are common in stable chronic obstructive pulmonary disease (COPD). While A. fumigatus sensitization correlates with poor lung function, the clinical impact of fungal presence in COPD requires further investigation.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Immunology
Background:
- Bacteria are frequently found in stable chronic obstructive pulmonary disease (COPD).
- The prevalence and clinical significance of fungal presence in COPD remain unclear.
- Investigating fungal colonization and sensitization in COPD is crucial for understanding disease pathology.
Purpose of the Study:
- To determine the frequency of filamentous fungal cultures in COPD subjects.
- To assess IgE sensitization to Aspergillus fumigatus in COPD patients.
- To explore the relationship between fungal presence/sensitization and clinical outcomes in COPD.
Main Methods:
- A 1-year observational study involving COPD subjects and healthy controls.
- Sputum analysis for inflammation, bacteria, and fungi.
- Lung function tests and allergen testing for Aspergillus fumigatus sensitization.
Main Results:
- Filamentous fungi were cultured in 49% of COPD subjects, with A. fumigatus being the most common.
- A. fumigatus sensitization was found in 13% of COPD subjects and linked to worse lung function (p=0.01).
- Positive fungal culture in COPD patients correlated with increased sputum cell counts and inhaled corticosteroid dosage.
Conclusions:
- Filamentous fungal colonization is a common finding in stable COPD.
- Aspergillus fumigatus sensitization is associated with impaired lung function in COPD.
- The precise clinical significance of filamentous fungi in COPD requires further research.
Related Concept Videos
Fungal Phylum Ascomycota
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Asthma III: Clinical Manifestations
